Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors

  • S. Feola, C. Capasso, M. Fusciello, B. Martins, S. Tähtinen, M. Medeot, S. Carpi, F. Frascaro, E. Ylosmäki, K. Peltonen, L. Pastore, V. Cerullo
  • OncoImmunology, April 2018, Taylor & Francis
  • DOI: 10.1080/2162402x.2018.1457596

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Prof. Lucio Pastore